AU3216289A - Paramagnetic compounds comprising chelating moiety, linker group macro molecule and paramagnetic metal - Google Patents

Paramagnetic compounds comprising chelating moiety, linker group macro molecule and paramagnetic metal

Info

Publication number
AU3216289A
AU3216289A AU32162/89A AU3216289A AU3216289A AU 3216289 A AU3216289 A AU 3216289A AU 32162/89 A AU32162/89 A AU 32162/89A AU 3216289 A AU3216289 A AU 3216289A AU 3216289 A AU3216289 A AU 3216289A
Authority
AU
Australia
Prior art keywords
paramagnetic
linker group
chelating moiety
compounds
macro molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU32162/89A
Other versions
AU623901B2 (en
Inventor
Jo Klaveness
Pal Rongved
Per Strande
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare AS
Original Assignee
Nycomed AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888801646A external-priority patent/GB8801646D0/en
Application filed by Nycomed AS filed Critical Nycomed AS
Publication of AU3216289A publication Critical patent/AU3216289A/en
Application granted granted Critical
Publication of AU623901B2 publication Critical patent/AU623901B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/12Macromolecular compounds
    • A61K49/126Linear polymers, e.g. dextran, inulin, PEG
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/24Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
AU32162/89A 1988-01-26 1989-01-26 Paramagnetic compounds comprising chelating moiety, linker group macro molecule and paramagnetic metal Ceased AU623901B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB8801646 1988-01-26
GB888801646A GB8801646D0 (en) 1988-01-26 1988-01-26 Chemical compounds
PCT/EP1989/000078 WO1989006979A1 (en) 1988-01-26 1989-01-26 Paramagnetic compounds

Publications (2)

Publication Number Publication Date
AU3216289A true AU3216289A (en) 1989-08-25
AU623901B2 AU623901B2 (en) 1992-05-28

Family

ID=26069637

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32162/89A Ceased AU623901B2 (en) 1988-01-26 1989-01-26 Paramagnetic compounds comprising chelating moiety, linker group macro molecule and paramagnetic metal

Country Status (3)

Country Link
AU (1) AU623901B2 (en)
DE (1) DE68901924T2 (en)
NO (1) NO903307D0 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU628403B2 (en) * 1988-09-29 1992-09-17 Access Pharmaceuticals, Inc. Methods and compositions for magnetic resonance imaging

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10040381C1 (en) * 2000-08-11 2002-06-06 Schering Ag Perfluoroalkyl-containing complexes with sugar residues, process for their preparation and their use
US6641797B2 (en) 2000-08-11 2003-11-04 Schering Aktiengesellschaft Perfluoroalkyl-containing complexes with sugar radicals, process for their production and their use
DE102014016901B4 (en) * 2014-09-17 2021-08-12 Friedrich-Schiller-Universität Jena Process for the production of new dextran derivatives as active ingredient carrier systems and their use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07110815B2 (en) * 1985-11-18 1995-11-29 ボ−ド・オブ・リ−ジェンツ、ザ・ユニバ−シティ−・オブ・テキサス・システム Polychelating agent for image and spectral enhancement (and spectral shift)
ZA894792B (en) * 1988-06-24 1991-04-24 Dow Chemical Co Macrocyclic bifunctional chelants,complexes thereof and their antibody conjugates
DK169306B1 (en) * 1989-06-14 1994-10-10 Af 18 Juni 1990 As Means for removing or inactivating unwanted components in blood or other extracellular body fluids and method of preparing dextran-O-carbonyl-benzo-18-crown-6 and of dextran-hydroxyethylbenzo-18-crown-6

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU628403B2 (en) * 1988-09-29 1992-09-17 Access Pharmaceuticals, Inc. Methods and compositions for magnetic resonance imaging

Also Published As

Publication number Publication date
NO903307L (en) 1990-07-25
DE68901924D1 (en) 1992-07-30
AU623901B2 (en) 1992-05-28
NO903307D0 (en) 1990-07-25
DE68901924T2 (en) 1992-12-10

Similar Documents

Publication Publication Date Title
GB2270920B (en) Alginate-bioactive agent conjugates
EP0802334A4 (en) Connecting mechanism for structural members
GB8902183D0 (en) Elastomer-forming compositions
EP0364509A4 (en) Cellular toxic conjugates.
ZA901086B (en) Conjugates
GB2270522B (en) Elastomer-forming composition
GB2232547B (en) Amplifiers
AU3216289A (en) Paramagnetic compounds comprising chelating moiety, linker group macro molecule and paramagnetic metal
GB9300611D0 (en) Elastomer-forming composition
AU7661991A (en) Chelating agents
GB9021325D0 (en) Chemical composition
GB9021051D0 (en) Catalyst composition
GB2238317B (en) Fe-Cr-Ni-Al ferritic alloys
GB9319961D0 (en) Photopolymerisable composition
GB9410989D0 (en) Indexing mechanism
GB9011412D0 (en) Catalyst composition
AU5044690A (en) Chelating agent derivatives
GB2249737B (en) Catalyst composition for coupling process
EP0406959A3 (en) Maleimide composition
ZA948255B (en) Alkoxylation process
EP0427048A3 (en) Metal complex compounds
AU2904789A (en) Macrocyclic chelating agents and chelates thereof
GB2240986B (en) Metal complex compounds
AU426P (en) AZTEC Macroptilium atropurpureum
EP0743318A4 (en) Novel anti-hiv agent